238 related articles for article (PubMed ID: 30988134)
21. Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli.
Li G; Kidd J; Kaspar C; Dempsey S; Bhat OM; Camus S; Ritter JK; Gehr TWB; Gulbins E; Li PL
Am J Pathol; 2020 Jun; 190(6):1211-1223. PubMed ID: 32194052
[TBL] [Abstract][Full Text] [Related]
22. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy.
Liu X; Cheng JC; Turner LS; Elojeimy S; Beckham TH; Bielawska A; Keane TE; Hannun YA; Norris JS
Expert Opin Ther Targets; 2009 Dec; 13(12):1449-58. PubMed ID: 19874262
[TBL] [Abstract][Full Text] [Related]
23. Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer.
Ruckhäberle E; Holtrich U; Engels K; Hanker L; Gätje R; Metzler D; Karn T; Kaufmann M; Rody A
Climacteric; 2009 Dec; 12(6):502-13. PubMed ID: 19905902
[TBL] [Abstract][Full Text] [Related]
24. Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.
Yu FPS; Sajdak BS; Sikora J; Salmon AE; Nagree MS; Gurka J; Kassem IS; Lipinski DM; Carroll J; Medin JA
Am J Pathol; 2019 Feb; 189(2):320-338. PubMed ID: 30472209
[TBL] [Abstract][Full Text] [Related]
25. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
[TBL] [Abstract][Full Text] [Related]
26. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.
Mahdy AE; Cheng JC; Li J; Elojeimy S; Meacham WD; Turner LS; Bai A; Gault CR; McPherson AS; Garcia N; Beckham TH; Saad A; Bielawska A; Bielawski J; Hannun YA; Keane TE; Taha MI; Hammouda HM; Norris JS; Liu X
Mol Ther; 2009 Mar; 17(3):430-8. PubMed ID: 19107118
[TBL] [Abstract][Full Text] [Related]
27. Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.
Sänger N; Ruckhäberle E; Györffy B; Engels K; Heinrich T; Fehm T; Graf A; Holtrich U; Becker S; Karn T
Mol Oncol; 2015 Jan; 9(1):58-67. PubMed ID: 25131496
[TBL] [Abstract][Full Text] [Related]
28. Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy.
Govindarajah N; Clifford R; Bowden D; Sutton PA; Parsons JL; Vimalachandran D
Crit Rev Oncol Hematol; 2019 Jun; 138():104-111. PubMed ID: 31092365
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of acid ceramidase (ASAH1) protects retinal cells (ARPE19) from oxidative stress.
Sugano E; Edwards G; Saha S; Wilmott LA; Grambergs RC; Mondal K; Qi H; Stiles M; Tomita H; Mandal N
J Lipid Res; 2019 Jan; 60(1):30-43. PubMed ID: 30413652
[TBL] [Abstract][Full Text] [Related]
30. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
31. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene.
Alves MQ; Le Trionnaire E; Ribeiro I; Carpentier S; Harzer K; Levade T; Ribeiro MG
Mol Genet Metab; 2013 Jul; 109(3):276-81. PubMed ID: 23707712
[TBL] [Abstract][Full Text] [Related]
33. rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.
Zhang H; Nagree MS; Liu H; Pan X; Medin JA; Lipinski DM
Gene Ther; 2023 Apr; 30(3-4):297-308. PubMed ID: 35902747
[TBL] [Abstract][Full Text] [Related]
34. Arterial Medial Calcification through Enhanced small Extracellular Vesicle Release in Smooth Muscle-Specific Asah1 Gene Knockout Mice.
Bhat OM; Li G; Yuan X; Huang D; Gulbins E; Kukreja RC; Li PL
Sci Rep; 2020 Feb; 10(1):1645. PubMed ID: 32015399
[TBL] [Abstract][Full Text] [Related]
35. Akt2 and acid ceramidase cooperate to induce cell invasion and resistance to apoptosis.
Berndt N; Patel R; Yang H; Balasis ME; Sebti SM
Cell Cycle; 2013 Jul; 12(13):2024-32. PubMed ID: 23777806
[TBL] [Abstract][Full Text] [Related]
36. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
[TBL] [Abstract][Full Text] [Related]
37. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities.
Lai M; La Rocca V; Amato R; Freer G; Pistello M
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336922
[TBL] [Abstract][Full Text] [Related]
39. DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.
Haynes TA; Filippov V; Filippova M; Yang J; Zhang K; Duerksen-Hughes PJ
Biochim Biophys Acta; 2012 Jul; 1821(7):943-53. PubMed ID: 22349266
[TBL] [Abstract][Full Text] [Related]
40. Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumors.
Voelkel-Johnson C
Semin Cancer Biol; 2022 Jun; 81():206-219. PubMed ID: 33429049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
